Diagnostic Odyssey of Atypical Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD ) Explained by Three Allelic Products From Two Pathogenic Variants
American Journal of Medical Genetics Part A · 2026-09 · 200 (9) · 2128-2135
DOI: 10.1002/ajmg.a.70172 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 27.04.2026. Verfasst von Yutaka Furuta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics and Genomic Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Lipid Metabolism, Inborn Errors, Mitochondrial Trifunctional Protein, Muscular Diseases, Rhabdomyolysis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, Potocsnak Center, National Human Genome Research Institute.
Abstract (Originalsprache)
Long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency (LCHADD) is an autosomal recessive mitochondrial defect of long‐chain fatty acid β‐oxidation, caused by biallelic pathogenic variants in HADHA or HADHB . We report a 22‐year‐old male with an atypically mild presentation of LCHADD who was referred to the Undiagnosed Diseases Network (UDN). Trio genome sequencing identified a maternally inherited HADHA frameshift pathogenic variant and a paternally inherited noncoding rare HADHA variant. The paternal noncoding variant was predicted by in silico splicing analysis to create a cryptic splice donor site. This was experimentally confirmed to partially perturb splicing, leading to partial disruption of normal splicing and the production of both normal and aberrant transcripts. Transcripts derived from the cryptic donor site were subject to nonsense‐mediated decay (NMD). As a result, the proband's cells produced three HADHA transcripts: a truncated maternal transcript that was destroyed by NMD, an abnormally spliced paternal transcript also subject to NMD, and a normally spliced paternal transcript. The presence of residual normally spliced HADHA transcripts from the paternal allele likely contributes to partial preservation of LCHAD enzyme function and provides a plausible explanation for the proband's attenuated clinical phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Genetics and Genomic Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Section of Genetics and Metabolism, Department of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock, Arkansas, USA.
- Department of Medical Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Yutaka Furuta, T Andrew Burrow, Thomas A Cassini, Rory J Tinker, Kimberly M Ezell
Förderung
- NHGRI NIH HHS
- Potocsnak Center
- National Human Genome Research Institute
Zitieren
APA
Furuta, Y., Rives, L. C., Burrow, T. A., Cassini, T. A., Tinker, R. J., Robertson, A. K., Ezell, K. M., Hamid, R., Cogan, J. D., & Phillips, J. A. (2026). Diagnostic Odyssey of Atypical Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD ) Explained by Three Allelic Products From Two Pathogenic Variants. American Journal of Medical Genetics Part A, 200(9), 2128-2135. https://doi.org/10.1002/ajmg.a.70172
Vancouver
Furuta Y, Rives LC, Burrow TA, Cassini TA, Tinker RJ, Robertson AK, et al. Diagnostic Odyssey of Atypical Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD ) Explained by Three Allelic Products From Two Pathogenic Variants. American Journal of Medical Genetics Part A. 2026;200(9):2128-2135. doi:10.1002/ajmg.a.70172
BibTeX
@article{Furuta2026,
author = {Furuta, Yutaka and Rives, Lynette C and Burrow, T Andrew and Cassini, Thomas A and Tinker, Rory J and Robertson, Amy K and Ezell, Kimberly M and Hamid, Rizwan and Cogan, Joy D and Phillips, John A},
title = {Diagnostic Odyssey of Atypical Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD ) Explained by Three Allelic Products From Two Pathogenic Variants},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {9},
pages = {2128--2135},
doi = {10.1002/ajmg.a.70172}
}
EUVIMED